$AMRZ

Amrize Ltd

No enriched coverage for $AMRZ in the last 7 days.

No SEC Form 4 filings for $AMRZ in the last 30 days.

Med

Amrize Ltd (AMRZ) Reports Q1 Earnings: What Key Metrics Have to Say

Amrize Ltd (AMRZ) reported Q1 earnings with revenue of $2.18 billion, showing no change year-over-year, and an EPS of -$0.16. The company surpassed the Zacks Consensus Estimate for revenue but missed on EPS. Key metrics like Building Materials revenue and Adjusted EBITDA for Building Materials exceeded analyst expectations, while others like Building Envelope revenue and Adjusted EBITDA for Building Envelope and unallocated corporate costs fell short.

Amrize appoints Baris Oran as CFO; Ian Johnston to senior advisor

Amrize has announced the appointment of Baris Oran as its new Chief Financial Officer, effective April 1, 2026. Ian Johnston, the outgoing CFO, will transition to a senior advisor role and will be on garden leave until March 31, 2027, to support the transition. The change is not related to any disagreements regarding financial controls or operations.